AI
PLRX icon

Atom Investors’s Pliant Therapeutics PLRX Stock Holding History

Atom Investors’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-130,448
Closed -$1.72M – 618
2024
Q4 		$1.72M Buy
+130,448
New +$1.78M 0.21% 145
2024
Q2 		– Sell
-58,064
Closed -$865K – 619
2024
Q1 		$865K Sell
58,064
-8,297
-13% -$137K 0.11% 244
2023
Q4 		$1.2M Buy
66,361
+19,210
+41% +$292K 0.21% 162
2023
Q3 		$818K Buy
47,151
+33,085
+235% +$574K 0.19% 157
2023
Q2 		$255K Sell
14,066
-8,806
-39% -$208K 0.1% 209
2023
Q1 		$608K Sell
22,872
-16,547
-42% -$471K 0.33% 83
2022
Q4 		$762K Buy
39,419
+16,722
+74% +$350K 0.38% 67
2022
Q3 		$474K Buy
+22,697
New +$434K 0.17% 154

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Atom Investors's PLRX Position: Q1 2025 in Review

Atom Investors sold out of Pliant Therapeutics (PLRX) in Q1 2025, closing a stake of 130,448 shares — an estimated $1.72M sold.

Atom Investors first reported a position in PLRX in Q3 2022 and held it in 8 quarters. The position peaked at $1.72M in Q4 2024. 140 funds tracked by Wall St. Rank hold PLRX as of Q1 2025.

  • Atom Investors reported no remaining Pliant Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Atom Investors sold 130,448 Pliant Therapeutics shares in Q1 2025, an estimated $1.72M.
  • Atom Investors first reported a position in Pliant Therapeutics in Q3 2022 and held it in 8 quarters.
  • Atom Investors's Pliant Therapeutics position peaked at $1.72M in Q4 2024.
  • 140 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2025.

Based on Atom Investors's 13F filing for Q1 2025, filed 15 May 2025.